InterVene, Inc. recently announced that it has received 510(k) clearance from the FDA for its Recana thrombectomy catheter ...
US FDA grants 510(k) clearance to InterVene’s Recana Thrombectomy Catheter System for venous in-stent restenosis and native vessel obstructions: Redwood City, California Monday, ...
Introduction AIxMed, a recognized innovator in AI diagnostics for urine cytology, and PathNet, a leading diagnostic laboratory, announced a strategic partnership. This collaboration aims to enhance ...
InterVene, Inc., a privately held medical device company pioneering interventional devices for venous occlusions, today announced it received 510(k) clearance from the U.S. Food and Drug ...
Objective To characterise and quantify the mortality risks for a range of causes after tropical cyclones in nine countries ...
particularly in patients with thrombotic pathology. According to California-based InterVene, Recana is the first fully integrated platform for treating in-stent and native vessel obstructions. It ...
Letby was accused of murdering seven babies and attempting to murder seven others at the Countess of Chester Hospital between ...
Variations in definitions and methodologies have created differences in the results and conclusions obtained from studies of football (soccer) injuries, making interstudy comparisons difficult.
Professor Derek Yellon discusses the increasing prevalence of cardiovascular diseases (CVD) in Africa and the associated treatment challenges ...
Objectives To characterise the aetiological spectrum of thoracic granulomatous diseases and identify diagnostic features that facilitate differentiation among causes. Design Retrospective multicentre ...
Amid unprecedented scientific progress in oncology, a growing body of evidence reveals a parallel and profound crisis in the human experience of cancer care. Despite overall survival outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback